BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 18630936)

  • 1. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
    Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
    Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.
    Mellaerts R; Roeffaers MB; Houthoofd K; Van Speybroeck M; De Cremer G; Jammaer JA; Van den Mooter G; Augustijns P; Hofkens J; Martens JA
    Phys Chem Chem Phys; 2011 Feb; 13(7):2706-13. PubMed ID: 21152589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials.
    Mellaerts R; Aerts CA; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
    Chem Commun (Camb); 2007 Apr; (13):1375-7. PubMed ID: 17377687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole.
    Van Speybroeck M; Mols R; Mellaerts R; Thi TD; Martens JA; Van Humbeeck J; Annaert P; Van den Mooter G; Augustijns P
    Eur J Pharm Biopharm; 2010 Aug; 75(3):354-65. PubMed ID: 20420905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen.
    Vialpando M; Backhuijs F; Martens JA; Van den Mooter G
    Eur J Pharm Biopharm; 2012 May; 81(1):190-8. PubMed ID: 22306694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
    Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
    Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
    Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
    Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of amorphous microporous silica for ibuprofen controlled release.
    Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
    Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
    Shen SC; Ng WK; Chia L; Hu J; Tan RB
    Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.
    Hu Y; Wang J; Zhi Z; Jiang T; Wang S
    J Colloid Interface Sci; 2011 Nov; 363(1):410-7. PubMed ID: 21820127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
    Song SW; Hidajat K; Kawi S
    Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
    Zhu S; Zhou Z; Zhang D
    Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fenofibrate-mesoporous silica drug-loading processes for enhanced drug delivery.
    Ahern RJ; Hanrahan JP; Tobin JM; Ryan KB; Crean AM
    Eur J Pharm Sci; 2013 Nov; 50(3-4):400-9. PubMed ID: 23981335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.